Tremor News and Research

Latest Tremor News and Research

Researchers challenge conventional understanding of cause of Parkinson's

An international team of researchers involving members of the University of Basel's Biozentrum challenges the conventional understanding of the cause of Parkinson's disease.

26 Jun 2019

New radiation technique shows promise for treating patients with essential tremor

Tyrus Agee thought his promising new career was doomed. He had only one year left to finish his Doctor of Optometry degree at the University of Alabama at Birmingham School of Optometry.

16 Jun 2019

Scientists identify potential target for Parkinson's treatment

An international research team led by scientists at the University of Alabama at Birmingham has identified a potential target for therapeutics that might help slow the progression of Parkinson's disease.

12 Jun 2019

Appendix removal linked to increased risk of Parkinson's disease

People who have had their appendix removed may be at an increased risk for developing Parkinson’s disease, according to new research.

10 May 2019

Study reveals vitamin B12 as inhibitor of key enzyme in hereditary Parkinson's disease

Iban Ubarretxena, an Ikerbasque Researcher and Director of the Biofisika Institute, participates in a piece of research that has enabled new inhibitors to be identified and which could be used to develop drugs to combat Parkinson's.

3 Apr 2019

Researchers develop new technology to mass produce cerebral cortex neurons

Korea Brain Research Institute (KBRI, President Pann Ghill Suh) announced on Mar. 4 that its research team led by principal researcher Yoichi Kosodo developed a technology to mass produce cerebral cortex neurons utilizing Induced pluripotent Stem Cells.

28 Mar 2019

New study aims to detect Parkinson's at much earlier stage

A large study jointly led by Queen Mary University of London and UCL aims to identify people at risk of developing Parkinson's, years before the condition is currently detected, with a view to treating and alleviating it at a much earlier stage.

13 Mar 2019

Parkinson's treatment boosts the number and strength of brain cell 'batteries'

Scientists have gained clues into how a Parkinson's disease treatment, called deep brain stimulation, helps tackle symptoms.

13 Mar 2019

Mid-Atlantic researchers receive grant to test VibeForward device for Parkinson's patients

A Mid-Atlantic research team with roots at the University of Delaware has received a $440,000 grant from The Michael J. Fox Foundation for Parkinson's Research to test a device, called VibeForward, that uses vibration therapy to reduce symptoms of freezing of gait in patients with Parkinson's disease.

5 Mar 2019

Exercise has potential to improve non-motor symptoms of Parkinson's disease

Exercise has potential to improve non-motor as well as motor symptoms of Parkinson's disease, including cognitive function, report investigators in a review published in the Journal of Parkinson's Disease.

4 Mar 2019

New strategy may alleviate motor disorders in Parkinson's patients

Scientists of the German Center for Neurodegenerative Diseases and the University Medical Center Goettingen have been able to alleviate motor disorders in mice that resemble those seen in Parkinson's patients.

28 Feb 2019

RNAs are involved in protein aggregation and neurodegenerative diseases, research reveals

New research reveals RNAs, which are crucial for cells to produce proteins, are also involved in protein aggregation, where proteins do not fold properly and 'clump' together into aggregates. If cells cannot clear these away, they become toxic and prevent cells working properly.

8 Feb 2019

Researchers identify blood-based biomarkers of Parkinson's disease

Researchers at University of California San Diego School of Medicine and Arizona State University have received funding from The Michael J. Fox Foundation for Parkinson's Research to launch a multi-year, $1.7-million effort to identify blood-based biomarkers of Parkinson's disease, which could improve care and accelerate new treatments for the neurodegenerative disorder, which affects nearly 1 million Americans, with 60,000 new cases diagnosed annually.

5 Feb 2019

PET imaging post-HBOT shows improvement in brain metabolism in Alzheimer’s disease

Dr. Paul Harch, Clinical Professor and Director of Hyperbaric Medicine at LSU Health New Orleans School of Medicine, and Dr. Edward Fogarty, Chairman of Radiology at the University of North Dakota School of Medicine, report the first PET scan-documented case of improvement in brain metabolism in Alzheimer's disease in a patient treated with hyperbaric oxygen therapy.

24 Jan 2019

FDA approves generic drug for treating focal seizures

The U.S. Food and Drug Administration approved the first generic version of Sabril (vigabatrin) 500 mg tablets for treating complex partial seizures, also called focal seizures, as an adjunctive therapy (given with another primary treatment) in patients 10 years and older who have responded inadequately to several alternative (refractory) treatments.

16 Jan 2019

New, scalpel-free treatment for reducing Parkinson's tremor gets FDA approval

The federal Food and Drug Administration has approved a new, scalpel-free treatment for tremor in patients with medication-resistant Parkinson's disease.

15 Jan 2019

Pacemaker in the brain could help patients with epilepsy and Parkinsons

Engineers and researchers at the University of California, Berkeley have developed a neurostimulator that can act as a pacemaker within the human brain.

1 Jan 2019

Advanced stem cell approach could help fight Parkinson's disease

Scientists have taken a key step towards improving an emerging class of treatments for Parkinson's disease.

20 Dec 2018

High-tech brain surgery improves quality of life for people with Parkinson's disease

A high-tech form of brain surgery that replaces scalpels with sound waves improved quality of life for people with Parkinson's disease that has resisted other forms of treatment, a new study has found.

9 Nov 2018

Newly discovered compound shows potential for treating Parkinson's disease

A joint research group centered around Professor Hideyuki Okano and Associate Professor Jun Kohyama, Department of Physiology of the Keio University School of Medicine, together with a research group of Eisai Co., Ltd. has identified a compound that has the potential to be a treatment for Parkinson's disease by using dopaminergic neurons differentiated from induced pluripotent stem (iPS) cells from patients with familial Parkinson's disease.

19 Oct 2018